Literature DB >> 10665192

Fibrous dysplasia of the temporal bone: report of a case and a review of its characteristics.

C E Papadakis1, C E Skoulakis, E P Prokopakis, A A Nikolidakis, J G Bizakis, G A Velegrakis, E S Helidonis.   

Abstract

Fibrous dysplasia is an uncommon benign disorder of unknown etiology. It represents a disturbance of normal bone development--specifically a defect in osteoblastic differentiation and maturation that originates in the mesenchymal precursor of the bone. Because fibrous dysplasia shows a predilection for the facial and cranial bones, where it causes deformity and dysfunction, the disease is of particular interest to the otolaryngologist. In this paper, we report a case of fibrous dysplasia of the temporal bone, the first symptom of which was a mixed hearing loss. We discuss the characteristic features of this specific location of the disease, the differential diagnosis, and the treatment policy. We also address the issue of secondary sensorineural hearing loss.

Entities:  

Mesh:

Year:  2000        PMID: 10665192

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  3 in total

1.  Fibrous dysplasia of the temporal bone secondary to ear surgery: a case report.

Authors:  Adriana Pardo-Maza; Luis Lassaletta; Elena Ruiz-Bravo; Rosa Perez-Mora; Julio Peñarrocha; Javier Gavilan
Journal:  J Med Case Rep       Date:  2015-06-02

2.  Disrupted bone remodeling leads to cochlear overgrowth and hearing loss in a mouse model of fibrous dysplasia.

Authors:  Omar Akil; Faith Hall-Glenn; Jolie Chang; Alfred Li; Wenhan Chang; Lawrence R Lustig; Tamara Alliston; Edward C Hsiao
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

3.  Bony Cyst in a Ground Glass Matrix: A Rare Case Report of Craniofacial Fibrous Dysplasia with Secondary Aneurysmal Bone Cyst.

Authors:  Chandrika Sachar; Aakanksha Agarwal; Anjum Syed
Journal:  Indian J Radiol Imaging       Date:  2022-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.